Portable Microfluidic Platform Developed for Detecting Coronavirus Using Smartphone
Researchers headed by a team at the University of Illinois, Urbana-Champaign, have developed what they claim is an inexpensive, sensitive smartphone-based device that can detect viral and bacterial pathogens in about 30 minutes, and...
Bayer, Novartis, and Trump convicted by Nature – European Biotechnology
The politically overhyped use of old malaria drugs in combination with COVID-19-specific candidates has been demonstrated to be dangerous, reports Nature Medicine.
In the prestigous paper Nature Medicine, cardiologists under Lior Jankelson report that patients...
Scientists are developing synthetic COVID-19 antibody to treat sick patients
A team of researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with GenScript, is developing a synthetic antibody to SARS-CoV-2, the virus that causes coronavirus disease (COVID-19). This antibody is...
Novotech: Many countries in Asia-Pacific are fast-tracking COVID-19 clinical trials
The Asia-Pacific's largest specialist biotech CRO Novotech said many countries in the region were now fast-tracking their COVID-19 clients' clinical trials with expedited review processes for treatment and vaccine candidates.
A Novotech client's COVID-19 trial...
RIT scientists develop first 3D mass estimate of microplastic pollution in Lake Erie
Study shows different types of plastics accumulating in different portions of the lake
Credit: RIT
Rochester Institute of Technology scientists have developed the first three-dimensional mass estimate to...
Nanomedicine Method May Allow for Targeted Cancer Therapy
Scientists from the Japan Advanced Institute of Science and Technology (JAIST) and Centre national de la recherche scientifique (CNRS), and their colleagues say they have developed a type of nanomedicine based on multi-functional graphene...
Industry Analysis: Should You Buy Cara Therapeutics Inc (CARA) in Biotechnology? – InvestorsObserver
Cara Therapeutics Inc (CARA) is around the top of the Biotechnology industry according to InvestorsObserver. CARA received an overall rating of 70, which means that it scores higher than 70 percent of all stocks....
U.K. Starts Oxford Coronavirus Vaccine Trial as Germany Green-Lights BioNTech and Pfizer
The first human trials of a coronavirus vaccine developed by researchers at the University of Oxford will start today in the U.K. Making the announcement at a recent press briefing, U.K. government Health Secretary...
Drug from worms dampens autoimmune response – European Biotechnology
German researchers have isolated a substance from parasitic roundworm larvae to alleviate inflammation and treat asthma in a rodent model.
According to researchers headed by Julia Esser-von Bieren from Helmholtz Center Munich, Germany, the products...
Emergex partners with George Mason University for highly pathogenic RNA virus studies
Reviewed by Emily Henderson, B.Sc.Apr 22 2020
Emergex Vaccines Holding Limited ('Emergex'), a biotechnology company developing CD8+ priming set-point vaccines to prevent serious infectious diseases, today announced that it has entered into an agreement with...
